Skip to Content
Merck
CN

DLG2 variants in patients with pubertal disorders.

Genetics in medicine : official journal of the American College of Medical Genetics (2020-04-29)
Youn Hee Jee, Sehoon Won, Julian C Lui, Melissa Jennings, Philip Whalen, Shanna Yue, Adrian G Temnycky, Kevin M Barnes, Tim Cheetham, Matthew G Boden, Sally Radovick, Richard Quinton, Ellen W Leschek, Greti Aguilera, Jack A Yanovski, Stephanie B Seminara, William F Crowley, Angela Delaney, Katherine W Roche, Jeffrey Baron
ABSTRACT

Impaired function of gonadotropin-releasing hormone (GnRH) neurons can cause a phenotypic spectrum ranging from delayed puberty to isolated hypogonadotropic hypogonadism (IHH). We sought to identify a new genetic etiology for these conditions. Exome sequencing was performed in an extended family with autosomal dominant, markedly delayed puberty. The effects of the variant were studied in a GnRH neuronal cell line. Variants in the same gene were sought in a large cohort of individuals with IHH. We identified a rare missense variant (F900V) in DLG2 (which encodes PSD-93) that cosegregated with the delayed puberty. The variant decreased GnRH expression in vitro. PSD-93 is an anchoring protein of NMDA receptors, a type of glutamate receptor that has been implicated in the control of puberty in laboratory animals. The F900V variant impaired the interaction between PSD-93 and a known binding partner, Fyn, which phosphorylates NMDA receptors. Variants in DLG2 that also decreased GnRH expression were identified in three unrelated families with IHH. The findings indicate that variants in DLG2/PSD-93 cause autosomal dominant delayed puberty and may also contribute to IHH. The findings also suggest that the pathogenesis involves impaired NMDA receptor signaling and consequently decreased GnRH secretion.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-NMDAR2B Antibody, phosphoTyr 1472, Chemicon®, from rabbit